Residual neuromuscular blockade following electroconvulsive therapy

Area of Science:

• Anesthesiology
• Neuromuscular blockade
• Electroconvulsive therapy

Background:

• Post-procedural residual neuromuscular paralysis is a known complication in general surgery.
• Data on residual neuromuscular blockade following electroconvulsive therapy (ECT) is lacking.
• Current guidelines do not mandate neuromuscular monitoring for ECT.

Purpose of the Study:

• To determine the incidence of residual neuromuscular blockade after ECT.
• To assess the clinical significance of residual neuromuscular blockade in ECT patients.

Main Methods:

• Prospective observational audit conducted at a single center.
• Analysis of 23 electroconvulsive therapy (ECT) procedures.
• Assessment of residual neuromuscular blockade post-procedure.

Main Results:

• 14 out of 23 patients (61%) exhibited potentially clinically significant residual neuromuscular blockade.
• Median suxamethonium dose was 0.83mg/kg.
• Significant incidence of residual neuromuscular blockade observed.

Conclusions:

• Residual neuromuscular blockade is a frequent complication following ECT.
• Further research is warranted to understand the scope and significance of this complication.
• Consideration of neuromuscular monitoring in ECT protocols may be necessary.